Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BriOri’s targeted delivery of innovative treatment regimens will improve patient outcomes. Pediatric patients are one of many groups who will benefit. BriOri is also working on a next-generation medication combination with the potential to neutralize neuropathic pain and render opioid use obsolete. BriOri BioTech is developing new options for opioid-free pain relief.

List your booth number for exhibitions, ask us